Non-Versican mRNAs with partial sequence complementarity

Non-Versican mRNAs with partial sequence complementarity refers to a diverse set of messenger RNA (mRNA) molecules that share sequence motifs, specifically microRNA response elements (MREs), with the Versican (VCAN) transcript. This group is central to the competitive endogenous RNA (ceRNA) network, where the VCAN 3' untranslated region (UTR) functions as a molecular "sponge" for various microRNAs such as miR-144, miR-199a, and miR-133a (Lee et al., 2010, Cell Cycle). By sequestering these miRNAs, VCAN indirectly prevents the degradation of these non-VCAN mRNAs, thereby modulating the expression of genes involved in cell proliferation, metastasis, and tissue remodeling (Fang et al., 2013, PLOS ONE). In the context of drug development, these mRNAs are primarily viewed as potential off-target sites for VCAN-specific RNA interference (RNAi) therapies or antisense oligonucleotides. Partial sequence complementarity between a therapeutic agent and these non-target mRNAs can lead to unintended gene silencing, which poses a significant safety concern and therapeutic challenge (Jackson & Linsley, 2010, Nature Reviews Drug Discovery). Consequently, while not a therapeutic target itself, this class of molecules is critical for understanding the systemic biological impact of VCAN dysregulation and for ensuring the specificity of RNA-based drugs.

Other names

Off-target mRNAsVCAN-related ceRNA network membersVersican-competing transcriptsmiRNA-mediated VCAN targets

Indirect regulation via microRNA sequestration (ceRNA effect) and unintended gene silencing through off-target RNA interference (RNAi) hybridization.